-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Bendamustine is a chemotherapy drug that is used to treat various types of cancer, including chronic lymphocytic leukemia (CLL), follicular lymphoma, and multiple myeloma.
It is also known by its chemical name, (2S)-2-[(2R)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide.
Bendamustine is classified as an alkylating agent, which means that it damages the DNA of cancer cells and prevents them from dividing and growing.
It works by attaching to the DNA of cancer cells and causing mutations that disrupt the normal functioning of the cells.
Bendamustine is typically administered intravenously, either as a bolus dose or as a continuous infusion.
The dosage and frequency of treatment will depend on the specific type of cancer being treated, as well as the patient's individual health status.
Bendamustine is typically well-tolerated, but it can cause certain side effects, such as nausea, vomiting, diarrhea, and hair loss.
These side effects are usually temporary and will improve after treatment is completed.
In addition to its use in cancer treatment, bendamustine is also being investigated as a potential treatment for other medical conditions, such as multiple sclerosis and Alzheimer's disease.
Bendamustine is a powerful drug that is used to treat various types of cancer.
It is classified as an alkylating agent, which means
